Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Ann Surg Oncol. 2008 Oct 1;15(12):3550–3560. doi: 10.1245/s10434-008-0163-0

TABLE 2.

Characteristics of 181 Patients Age ≥ 16 Who Died from Low Grade Sarcoma Following Resection with Curative Intent

Characteristic Number
(N=182)
%
Gender Male 98 54
Female 83 46

Age at Diagnosis Median 57
(16 – 90)

Site Extremity 32 18
Retroperitoneal/Intraabdominal 97 54
Trunk 19 10
Thoracic 8 4
Visceral 14 8
Head and Neck 10 6
Skin 1 0.5

Histology Liposarcoma 97 53
Desmoid/Fibromatosis 7 4
Dermatofibrosarcoma Protuberans (DFSP) 1 0.5
Malignant Fibrous Histiocytoma 21 12
Leiomyosarcoma 12 7
Solitary Fibrous Tumor/Hemangiopericytoma 6 3
Fibrosarcoma 14 8
Chondrosarcoma¶¶ 7 4
Other†† 16 9

Primary Tumor Size ≤ 5 cm 10 6
5-10 cm 50 28
> 10 cm 105 58
Unknown 16 9

Depth Deep 169 93
Superficial 11 6

Margin Status R0 82 45
R1 56 31
R2 29 16
Unknown 14 8

Radiotherapy Primary Tumor 42 23
Recurrent Disease 52 29

Chemotherapy Primary Tumor 22 12
Recurrent Disease 82 45

Cause of Death Local 105 58
Distant 59 32
Unknown 17 9

Median Time
to Recurrence
Local 29 months
(range 1 – 382)
Distant 74 months
(range 1 – 414)

Median Time to
Sarcoma-Specific
Death
Local 94 months
(range 3 – 328)
Distant 168 months
(range 9 – 432)

Because of rounding, not all percentages sum to 100.

Includes gynecologic 6/14 (43%), gastrointestinal 7/14 (50%), and genitourinary 1/14 (7%).

Analyses performed excluding patients with desmoids/fibromatosis obtained similar results.

¶¶

Includes extraskeletal myxoid chondrosarcoma 7/7 (100%)

††

Comprises 9 histologic subtypes including endometrial stromal sarcoma, adenosarcoma, angiosarcoma, dendritic cell tumor, malignant mesenchymoma, and sarcoma NOS among others.